NOVOS, which exports Turkish engineering expertise in neonatal intensive care technologies to the world, has expanded its global footprint by signing new “Exclusive Distributorship” agreements in five different countries as part of its 2026 strategic growth plan.

NOVOS, which has been producing technologies that keep babies alive in the most remote corners of the world for a quarter of a century, continues its remarkable success story in the global market as we head into 2026. In a move that demonstrates the company’s strength in the international market and the reliability of its distributor network, NOVOS announced that it has signed new exclusive distribution agreements in five different countries this year.

Thanks to these new exclusive partnerships covering strategic markets on different continents, NOVOS has not only secured its commercial operations under a single umbrella but has also paved the way for providing hospitals in these countries with uninterrupted, direct biomedical services and clinical training support that meet manufacturer standards.

“One Voice, One Standard Across 5 Countries”

Following the agreements reached, NOVOS General Manager Serpil Özdemir commented on this sharp rise in global market strategies, saying:
“2026 is shaping up to be a year in which we solidify our strength within our global distributor network. The five new exclusive distribution agreements we signed this year are the clearest indication of the global trust placed in our brand. The strong territorial protection and high market potential we offer our partners make NOVOS the top choice for medical device distributors worldwide. We will raise neonatal intensive care standards to the highest level in these five new countries as well.”